Literature DB >> 30548252

Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients.

Ulrich H Frey1,2, Marina Klaassen1, Crista Ochsenfarth1,2, Florian Murke3, Matthias Thielmann4, Eva Kottenberg1, Petra Kleinbongard5, Stefanie Klenke1, Andrea Engler1, Gerd Heusch5, Bernd Giebel3, Jürgen Peters1.   

Abstract

BACKGROUND: Remote ischaemic preconditioning (RIPC) can attenuate myocardial ischaemia/reperfusion injury but its underlying mechanisms remain largely unknown. Recently, extracellular vesicles (EVs) containing microRNAs (miRNAs) were shown to mediate distant intercellular communication that may be involved in cardioprotection. We tested the hypothesis that RIPC in anaesthetized patients undergoing coronary artery bypass (CABG) surgery results in the release of EVs from the ischaemic/reperfused arm into the blood stream harbouring cardioprotective miRNAs.
METHODS: In 58 patients randomised to RIPC (three 5/5 minutes episodes of left arm ischaemia/reperfusion by suprasystolic blood pressure cuff inflations/deflations) or Sham, a subprotocol comprising of parallel right radial artery and regional (left subclavian) venous blood sampling before (awake) and 5 and 60 minutes after RIPC/Sham during isoflurane/sufentanil anaesthesia could be completed. EVs were extracted by polymer-based precipitation methods, their concentrations measured, and their miRNA signature analysed.
RESULTS: Five minutes after RIPC, regional venous EV concentrations downstream from the cuff increased and arterial concentrations increased after 60 minutes (fold change [fc]: RIPC: 1.33 ± 0.5, Sham: 0.91 ± 0.31; P = 0.003 for interaction). Already 5 minutes after RIPC, expression of 26 miRNAs (threshold fc: 3.0, P < 0.05) isolated from EVs including the cardioprotective miR-21 had increased. RIPC also decreased postoperative Troponin I concentrations (AUC RIPC: 336 ng/mL × 72 hours ± 306 vs Sham: 713 ± 1013; P  =  0.041).
CONCLUSIONS: Remote ischaemic preconditioning increases serum EV concentrations, most likely by early EV release from the patients' left (RIPC) arm, alters their miRNA signature, and is associated with myocardial protection. Thus, an increased EV concentration with an altered miR-signature may mediate the RIPC effect.
© 2018 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30548252     DOI: 10.1111/aas.13296

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  18 in total

1.  Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study.

Authors:  Ignatios Ikonomidis; Dimitrios Vlastos; Ioanna Andreadou; Maria Gazouli; Panagiotis Efentakis; Maria Varoudi; George Makavos; Alkistis Kapelouzou; John Lekakis; John Parissis; Spiridon Katsanos; Damianos Tsilivarakis; Derek J Hausenloy; Dimitrios Alexopoulos; Dennis V Cokkinos; Hans-Eric Bøtker; Efstathios K Iliodromitis
Journal:  Basic Res Cardiol       Date:  2021-02-06       Impact factor: 17.165

2.  Remote ischemic preconditioning improves tissue oxygenation in a porcine model of controlled hemorrhage without fluid resuscitation.

Authors:  Gal Yaniv; Arik Eisenkraft; Lilach Gavish; Linn Wagnert-Avraham; Dean Nachman; Jacob Megreli; Gil Shimon; Daniel Rimbrot; Ben Simon; Asaf Berman; Matan Cohen; David Kushnir; Ruth Shaylor; Baruch Batzofin; Shimon Firman; Amir Shlaifer; Michael Hartal; Yuval Heled; Elon Glassberg; Yitshak Kreiss; S David Gertz
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

3.  Remote ischemic preconditioning protects against cerebral ischemia injury in rats by upregulating miR-204-5p and activating the PINK1/Parkin signaling pathway.

Authors:  Yiming Jiao; Jinlan Wang; Yanjie Jia; Mengzhou Xue
Journal:  Metab Brain Dis       Date:  2022-01-24       Impact factor: 3.584

4.  Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure.

Authors:  Frederik Abel; Florian Murke; Morten Gaida; Nicolas Garnier; Crista Ochsenfarth; Carsten Theiss; Matthias Thielmann; Petra Kleinbongard; Bernd Giebel; Jürgen Peters; Ulrich H Frey
Journal:  PLoS One       Date:  2020-02-14       Impact factor: 3.240

5.  Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles.

Authors:  Thomas Ravn Lassen; Jesper Just; Marie Vognstoft Hjortbak; Nichlas Riise Jespersen; Katrine Tang Stenz; Tingting Gu; Yan Yan; Junyi Su; Jakob Hansen; Rikke Bæk; Malene Møller Jørgensen; Jens Randel Nyengaard; Steen Buus Kristiansen; Kim Ryun Drasbek; Jørgen Kjems; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-03-10       Impact factor: 17.165

Review 6.  The role of microglia in ischemic preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Glia       Date:  2019-08-06       Impact factor: 8.073

7.  Nanoparticle delivery of cardioprotective therapies.

Authors:  Abraham Mendez-Fernandez; Hector A Cabrera-Fuentes; Bhaarathy Velmurugan; Jason Irei; William A Boisvert; Shengjie Lu; Derek J Hausenloy
Journal:  Cond Med       Date:  2020-02

8.  Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice.

Authors:  Zachary M Gertz; Chad Cain; Donatas Kraskauskas; Teja Devarakonda; Adolfo G Mauro; Jeremy Thompson; Arun Samidurai; Qun Chen; Sarah W Gordon; Edward J Lesnefsky; Anindita Das; Fadi N Salloum
Journal:  JACC CardioOncol       Date:  2019-12-17

Review 9.  MicroRNA Mediated Cardioprotection - Is There a Path to Clinical Translation?

Authors:  Timo Z Nazari-Shafti; Vasileios Exarchos; Héctor Rodriguez Cetina Biefer; Nikola Cesarovic; Heike Meyborg; Volkmar Falk; Maximilian Y Emmert
Journal:  Front Bioeng Biotechnol       Date:  2020-03-20

10.  Upregulation of miR‑423 improves autologous vein graft restenosis via targeting ADAMTS‑7.

Authors:  Wenjun Ren; Liwen Liang; Yongwu Li; Fei-Yu Wei; Ninghui Mu; Libin Zhang; Wei He; Yu Cao; Da Xiong; Hongrong Li
Journal:  Int J Mol Med       Date:  2019-12-05       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.